Literature DB >> 3135340

A study of indications used for removal of the mandibular third molar.

L Lysell1, M Rohlin.   

Abstract

To study the indications used for removal of the mandibular third molar, questionnaires were sent to 35 Oral Surgery Clinics in Sweden, out of which 29 clinics participated. In each clinic, the questionnaires were to be recorded for 30 patients. The indications for removal were classified into 15 groups. There were also questions about symptoms as well as eruption status for the molar being removed. The results were based on data from 870 individuals with a mean age of 27 years. More than half of the removed third molars (54%) presented no subjective symptoms. Such symptoms were more frequent in association with fully or partially erupted molars than molars completely covered by soft or bone tissue. The indication for removal was classified as prophylactic in 27% and as orthodontic in 14%. Earlier episodes of pericoronitis consisted of 1/4 of the indications and caries or pulpitis of the third molar made up 13%. Pathologic entities like cysts, tumours and root resorption were registered in less than 3% each, and were more frequent among patients 40 years of age or older.

Entities:  

Mesh:

Year:  1988        PMID: 3135340     DOI: 10.1016/s0901-5027(88)80022-5

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  17 in total

1.  Correlation of panoramic radiography and cone beam CT findings in the assessment of the relationship between impacted mandibular third molars and the mandibular canal.

Authors:  F S Neves; T C Souza; S M Almeida; F Haiter-Neto; D Q Freitas; F N Bóscolo
Journal:  Dentomaxillofac Radiol       Date:  2012-01-26       Impact factor: 2.419

Review 2.  A review of the indicator of sedation need (IOSN): what is it and how can it be improved?

Authors:  B Shokouhi; B Kerr
Journal:  Br Dent J       Date:  2018-01-26       Impact factor: 1.626

3.  Severe rotational drift of an impacted mandibular third molar: a case report.

Authors:  Ehsan Abouei Mehrizi; Mostafa Esmaeili; Gholamreza Eslami Amirabadi; Mohammadamin Narimani
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2010-09-16

4.  Prevalence of cysts and tumors around the retained and unerupted third molars in the Indian population.

Authors:  Santosh Patil; Vishal Halgatti; Suneet Khandelwal; B S Santosh; Sneha Maheshwari
Journal:  J Oral Biol Craniofac Res       Date:  2014-08-12

5.  Risk assessment of inferior alveolar neurovascular bundle by multidetector computed tomography in extractions of third molars.

Authors:  Frederico Sampaio Neves; Solange Maria de Almeida; Frab Norberto Bóscolo; Francisco Haiter-Neto; Marcelo Corrêa Alves; Iêda Crusoé-Rebello; Paulo Sérgio Flores Campos
Journal:  Surg Radiol Anat       Date:  2012-03-15       Impact factor: 1.246

6.  [Occurrence of epithelium in the soft tissues associated with routine surgical removal of 150 mandibular third molars].

Authors:  C Scheifele; H P Philipsen; P A Reichart
Journal:  Mund Kiefer Gesichtschir       Date:  2005-01

7.  Identifying the risk factors causing iatrogenic mandibular fractures associated with exodontia: a systemic meta-analysis of 200 cases from 1953 to 2015.

Authors:  Ajit Joshi; Manu Goel; Ashutosh Thorat
Journal:  Oral Maxillofac Surg       Date:  2016-09-23

8.  The predictivity of mandibular third molar position as a risk indicator for pericoronitis.

Authors:  Kemal Yamalik; Süleyman Bozkaya
Journal:  Clin Oral Investig       Date:  2007-07-10       Impact factor: 3.573

9.  Indications for removal of impacted mandibular third molars: a single institutional experience in Libya.

Authors:  B Krishnan; Mohammad Hossni El Sheikh; El-Gehani Rafa; H Orafi
Journal:  J Maxillofac Oral Surg       Date:  2009-11-21

10.  Assessment and determination of human mandibular and dental arch profiles in subjects with lower third molar impaction in Port Harcourt, Nigeria.

Authors:  Akinbami Babatunde Olayemi
Journal:  Ann Maxillofac Surg       Date:  2011-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.